*** Notice: For the protection of property rights, this catalog is available for online browsing only. Please drop us a line if you would like to receive a copiable version of this catalog. Thank You!
Brenda L. Haile, RN, DrPH; Joseph C Gathe, Jr., MD, FACP; Patricia D. Salvato, MD
Introduce to women, nurses and healthcare workers the latest information on HIV & AIDS as it relates to women; Be able to elaborate on current developments in the treatment of HIV and AIDS focusing on women; update the community on HIV & AIDS knowledge gained at the 12th World AIDS Conference in Geneva, Switzerland.
Kelly Scherbenske, RN; Laura A. Martin, RN; Maryann Kelly, CRNA, PhD
Discuss what identifies acute respiratory failure; List ten signs and symptoms a patient with acute respiratory failure might exhibit; identify five causes of acute respiratory failure that commonly confront emergency room personnel; explain the factors that predispose a patient to the development of acute respiratory distress syndrome in the ICU; identify persons at high risk for developing acute respiratory failure in the immediate postoperative period; discuss the criteria used in the diagnosis of acute respiratory failure; describe the impact that drugs have had on the treatment of acute respiratory failure; list the major indications for the use of mechanical ventilation for those patients with acute respiratory failure.
Susan Holcombe, RN, CCRN, MN; Marlene Link, RN; Jan George, RN
Be able to assess patient before and after inventional treament; know the benefits of an endotracheal tube for airway control rather that bag/valve/mask or mask or mouth to mouth; list potential enhancers of transthoracic resistance; know the proper use of the automated-external defibrillator; learn the drugs and dosage for each algorithm, endotracheal tube, calculate continuous infusions, differentiate stable/unstable symptoms.
Kevin M. Furmaga, PharmD; Michael Koronkowski, PharmD; Vinod Kumar, MD, MRC
Topics include: Pathophysiology and Non-Cognitive Symptoms of Alzheimer's Disease; Cognitive Symptoms of Alzheimer's Disease; Future Directions in Drug Therapy for Alzheimer's Disease.
Program provides participants w/ an update on new guidelines for the management of asthma, roles that pharmacists can play in the treatment of patients w/ asthma, and the role that medications affecting leukotriene synthesis or action may play in therapy.
Hiroshi Mitsumoto, MD; Deborah F. Gelinas, MD; Robert G. Miller, MD; Robert C. Griggs, MD; Daniel S. Newman, MD; Gabriel T. Tatarian, DO; Sharon Hulihan, ACSW
Overview of ALS care; clinical trials of potential treatments and experimental results - Riluzole and IGFI; Identifying goals of therapy and future directions for drug trials - BDNF; respiratory function; financial impact of ALS; symptomatic management and signs and symptoms of ALS .
Stephen L. Huber, MS, RPh; Cynthia Radford; Steven M. Grunberg, MD
This program features leading healthcare professionals giving presentations on the latest advances in the management of the side effects of chemotherapy. Discussions will include information on pharmacoeconomics of antiemetic therapy in oncology and appropriate use of antiemetic therapy. Specific topics include: Enhancing the Value of Antiemetics in Oncology; Reimbursement Environment in Antiemetic Therapy; Challenges in Antiemetic Therapy.
I. Craig Henderson, MD; John Kennedy, MD, FRCPI; William Gradishar, MD; Claudine Isaacs, MD
Leading medical experts making presentations on advances in the management and treatment of breast cancer, including new agents and combination therapies, emphasizing the role of chemotherapy.
Lawrence Stanberry, MD, PhD; Michael V. Reitano, MD; Stephen L. Sacks, MD, FRCPC; Larry Corey, MD; Charles Ebel
Asymptomatic Shedding and Transmission; Current use of Acyclovir for the Therapy of Genital Herpes; Treatment with vaccines; Treatment and suppression of recurrent Herpes Simplex: Famcyclovir; General clinical manifestations; What the patient's expectations are.
Walter J. Curran, Jr., MD; David S. Ettinger, MD; Chandra P. Belani, MD; Dawn Moose, MD
Integration of Chemotherapy and Radiation for Non-Small Cell Lung Cancer; New Drugs in Treatment of NSCLC; Recent Improvements in the Management of NSCLC; Management of Anorexia and Cachexia for Patients w/ NSCLC.
Walter J. Curran, Jr., MD; David S. Ettinger, MD; Chandra P. Belani, MD; Dawn Moose, MD
Integration of Chemotherapy and Radiation for Non-Small Cell Lung Cancer; New Drugs in Treatment of NSCLC; Recent Improvements in the Management of NSCLC; Management of Anorexia and Cachexia for Patients w/ NSCLC.
William G. Powderly, MD; John Rex, MD; David A. Stevens, MD; Bruce Polsky, MD; Joel B. Epstein, DMD, MSD; Marilyn Doyle, MD
Introduction to Oral Candidiasis; Resistance to Anti-Fungal; Oral Amphotericin B in the Management of Oral Candidiasis; Treatment of Thrush in Oncology Patients; Early Diagnosis and Treatment; Pediatric Treatment
Recognize and formally diagnose social phobia using DSM-IV; Differentiate social phobia from other primary and secondary anxiety disorders; Identify the disorders which tend to be commonly comorbid with social phobia; understand indications for drug therapy, cognitive behavior therapy, and combined treatment for social phobia; Describe classes of drugs most appropriate in treatment and first line treatments and follow-up treatment in case of non-response.
Phebe Tucker, MD; Lawrence J. Cohen, PharmD, FASHP; Charles B. Nemeroff, MD, PhD; Charles F. Reynolds III, MD; Kevin Scott Ferentz, MD
Explains short and long term treatment in the elderly, describes clinical drug therapy or treatment protocols, reviews disease management of depression in the managed care setting, discusses pharmacoeconomics of depression and explains the contemporary management of depression.
Karl Buetner, MD; Richard Whitley, MD; Robert Dworkin, MD; John F. Flahery, PharmD; John Wolf, MD
The Pain Benefit for Anti-Herpetic Therapy in the Elderly; Therapeutic Advances in H. Zoster; Pharmacokinetics and Differentiation of Anti-Viral Therapy; Herpes Zoster: Pain Analysis.
Karl Buetner, MD; Richard Whitley, MD; Robert Dworkin, MD; John F. Flahery, PharmD; John Wolf, MD
The Pain Benefit for Anti-Herpetic Therapy in the Elderly; Therapeutic Advances in H. Zoster; Pharmacokinetics and Differentiation of Anti-Viral Therapy; Herpes Zoster: Pain Analysis.
Tom Frieden, MD; John Bass, MD; John Sbarbaro, MD; Jeffery Stark, MD; William Bailey, MD
This program features presentations by an internationally prominent faculty of Tuberculosis experts and epidemiologists on guidelines for preventing and treating Tuberculosis infection. The objective of this program is to increase awareness among practicing physicians of the rise of TB in the United States in recent years and new information regarding treating drug resistant strains of the disease. Topics will include updated information with regard to prevention, vaccination, universal precautions for health care providers, high risk populations including patients with HIV, traditional drug therapies, and new and experimental drugs.
Provide a background for understanding the pharmacology efficacy and potential utility of a new class of antiretroviral agents, the non-nucleoside reverse transcriptase inhibitors
Advances in the management of HIV infection, including new strides in delaying the onset of full-blown AIDS. Studies involving drugs utilized in both a prophylactic and therapeutic capacity are discussed.
Mark Jacobson, MD; Vincent R. Bonagura, MD; William L. Holzemer, RN, PhD, FAAN; Daniel Kuritzkes, MD
Program will cover how HIV infected patients are diagnosed and monitored during therapy; learn the principles for delaying the onset of full-blown AIDS; Understand the adverse effects of the four groups of drugs: BPC, AZT, DDI, and DDC.
Michelle L. Robertson, RN, BSN, CIC; Earl Matthew, MD; Ellen Epstein, MS, MT(ASCP); Betty Edmond, Edward J. Septimus, MD
Discussing airborne pathogens in relation to healthcare facilities. Review airborne pathogens common to healthcare facilities and measures used to control them & enforcement of guidelines for preventing transmission of airborne pathogens.
Robert G. Nixon, BA, EMT-P; Jerry Douglas, MD; Ramona Stanfill, RN
This program will feature experts giving presentations on how to understand Alzheimer's disease and its effects. This program is designed to educate emergency medical professionals and nurses on the care of the patient with Alzheimer's disease, as well as dementia. This program will increase the viewer's awareness of Alzheimer's signs and symptoms, differentiate dementia from senility and focus on how to care for the patient with Alzheimer's disease.
Boni E. Elewski, MD; Hideoki Ogawa; David T. Roberts; Bardur Sigurgeirsson; Christa de Cuyper; D. O'Sullivan; Irving Katz, MD; E.G.V. Evans, PhD, FRCPath; R.J. Hay, DM, FRCPath
Understand the newest treatment regimens in onychomycosis therapy. Discuss the safety profile of antimycotics including side effects and drug interactions. Recognize the challenges in the management of onychomycosis. Discuss the long-term outcome of onychomycosis treatment.
Roman A. Torres, MD; Daniel Kuritzkes, MD; Paul A. Volberding, MD
When to Start Treatment; Importance of Drug Resistance in Devising Treatment Strategies; Research Update; Recognizing and circumventing drug interactions and side effects.
Stanley J. Szefler, MD; Harold S. Nelson, MD; Sally E. Wenzel, MD; G. Dennis Clifton, PharmD; Robert J. Kuhn, PharmD
Topics covered in this program include: the four major aspects of care in the approach to the management of asthma, the importance of allergy in asthma pathophysiology, the practical aspects of measuring the response to asthma management procedures and how they can be easily applied; different opportunities for improving the cost-effectiveness of asthma treatment; definition of the pharmacist's role in patient compliance and managed care .
Panelists: Alan Bernstein, PhD, FRSC; Michael Hayden, MD; Steve Holtzman; Phillip Reilly, JD, MD; Martin Rosenberg, PhD; Elizabeth Silverman; John Stevens, PhD; Lap-Chee Tsuy, OC, PhD; James Wilson, MD, PhD
This program explores the research on the human genome and its impact on healthcare. A panel of world class scientists and business executives will conduct discussions and there also some pre-taped presentations.
S. Atezar Saeed, MD; Williams S. Gilmer, MD; Timothy J. Bruce, PhD; Sandra Hable, RN, EdM., LCPC
Recognize and diagnose bipolar disorder using DSM-IV criteria; Address important diagnostic considerations in classifying bipolar disorder; Identify the disorders which tend to be commonly comorbid bipolar disorder; Describe the classes of drugs most appropriate for treatment and factors in choosing an appropriate first line treatment and follow-up treatments in case of non-response.
William U. Shipley, MD(Moderator); Derek Raghavan, MD, PhD; Harry W. Herr, MD; Mark S. Soloway, MD; M'Liss A. Hudson, MD; Niall M. Heney, MD; Paul F. Schellhammer, MD; Donald S. Kaufman, MD
Topics include superficial and invisible bladder cancer, diagnosis of patients presenting with either hematuria and dysuria, endoscopic and intravesical chemotherapeutic methods, systematic chemotherapy for advanced bladder cancer.
Earl Matthew, MD; Ellen Epstein, MS, MT(ATCP); Michelle L. Robertson, RN, BSN, CIC
This program describes the OSHA and state recognized definition of medical wastes and proper disposal, discusses measures utilized to control bloodborne pathogens in healthcare facilities and employee exposure needs, and identifies implications for nurses for control of bloodborne pathogens.
Laszlo Tabar, MD; Linda Warren, MD; Richard Bird, MD; Jeffery Weinreb, MD; Kevin Fox, MD; Barbara Fowble, MD; Michael Osborne, MD; John Hainsworth, MD
Topics included in this program are: The effectiveness of mammographic screening; the diagnostic workup: mammography, sonography, MRI; and therapeutic options: radiotherapy, chemotherapy, and surgury.
John Sandbach, MD; Gillian Newstead, MD; Christopher Merritt, MD; Ellen Mendelson, MD; Jeff Weinreb, MD; Mitch Schnall, MD
Role of mammography in the diagnosis of breast cancer, breast ultrasound, role of MRI in evaluation of breast disease, ultrasound guided fine needle aspiration.
Mary Totten, President, Totten & Associates; Ted Landsmark, President Boston Architectural Center; Philip Newbold, President & CEO, Memorial Health System
Develop a better understanding of the assets and resources in your community. Create partnership that makes the most effective use of your community's rescources. Understanding the changing role of the board from community relations to community health. Learn how to develop a community-focused mission. Become informed about what boards can do to ensure effective involvement in community health. Identify unmet needs in the community .
Leta Truett, RN, MN, CCRN; Deborah M. Thorpe, PhD, RN, CS; Mary Cunningham, RN, MS; Talulah Ruger, RN, BSN
This program features physicians and doctors discussing various appropriate nursing rules and interventions in pain management. The major areas of discussion are as follows: acute or post-operative pain management - current techniques and therapies, barriers to effective management; chronic non-malignant pain management or behavioral/cognitive pain management- classifications of chronic non-malignant pain characteristics, data collection, and treatment, cancer pain management - dosing regimens; nursing assessment for acute, chronic non-malignant or cancer pain - current therapies and techniques, point controlled analgesia (PCA), epidural analgesia.
Gabriel Hortobagyi, MD; Barbara L. Weber, MD; Charles L. Vogel, MD
Intro on the Management of Advanced Breast Cancer and the Use of Standard Chemotherapy; Current Hormonal Therapy and New Hormonal Agents in the Management of Breast Cancer; New Agents, including Taxol and Taxotere; Use of Navelbine and Clinical Trial Results.
Nicholas Petrelli, MD,FACS - Neal Meropol, MD - Tyvin Rich, MD - Alan Venook, MD
Topics include: surgical therapy of metastatic disease; new drugs in the treatment of metastatic disease; intrahepatic chemotherapy of colorectal liver metastasis; adjuvant combined modality therapy for colorectal cancer.
Richard Champlin, MD; Bruce D. Cheson, MD; Michael Bishop, MD; Frederick R. Appelbuam, MD; Frank J. Giles, MD; Charles A. Schiffer, MD
For physicians who have interest in or occasion to diagnose or treat cancer patients. Presentations will feature discussions about various leukemias and treatments of the disease.
Joseph Oesterling, MD; Arthur Porter, MD; Anthony Zeitman, MD; Jerry Ritchie, MD; David Paulson, MD; Michael K. Brawer, MD
Featured topics of this program include the use of PSA in diagnosis and staging of prostate cancer, transrectal ultrasound, improving the results of radical treatment for locally advanced prostate cancer, radical prostatectomy, maximum androgen deprivation therapy, and radionuclide therapy for metastatic prostate cancer.
Management of low grade lymphoma, status of interferon in Hon-Hodgkin's lymphoma, treatment of HIV/AIDS related lymphomas and treatment of low grade lymphoma.
Everett E. Vokes, MD; Vince Miller, MD; Gregory A. Masters, MD; Bruce Hillner, MD
Most recent data in standard therapy for Stage IV; Describe the role of concurrent and chemoradiation in Stage III and other treatment, including vinorelbine tartrate and platinol; Understand the pharmcoeconomic impact; Identify early clinical results of current investigation on drugs; Discuss neoadjuvant treatment.
Seth Lerner, MD; Ron Bukowski, MD; Chris Logothetis, MD; Richard Williams, MD; Michael Sorodsky, MD
This program deals with testes cancer; bladder cancer- BCG, alternatives to BCG therapy, and metastatic bladder cancer; and renal cell cancer - single agent therapies including IL-2 high dose and alpha interferon, combination therapy of IL-2 low dose and alpha interferon, and surgery to treat renal cell - does it improve survivability.
Maria J. De Jong, RN, MS, CCRN, CEN, Captain; Lisa Alexander, RN, CCRN; Tamara Pastor-Lacey, RN, MS, Major
This program focuses on the five causes and five clinical manifestations of cardiogenic shock. Viewers will be able to describe the pathophysiologic progression of cardiogenic shock, as well as management strategies for patients. Priority pharmacological treatments options and desired outcomes for patients with cardiogenic shock are discussed, plus a case study for a patient with cardiogenic shock will be analyzed.
John Kane, MD; Alan Chait, MD; John LaRose, MD; Tom Bersot, MD; Stephen G. Young, MD; Gustav Schoenfeld, MD; Virgil Brown, MD
Increasing awareness and importance of controlling cholesterol in patients with heart disease and other high risk individuals. Most recent NCEP guidelines for management of hypertension in adults.
Susan Simmons Holcomb, RN, MN, CCRN; Marlene Link, RN, MN; Jan George, RN, BSN, CCRN
List general complications related to interventional cardiology procedures; Identify antiplatelet drugs used to decrease restenosis; Name indications and contraindications to balloon angioplasty and its complications; Compare and contrast the atherectomy devices. Identify indications and contraindications to the use of intracoronary stents and state complications specific to intracoronary stents.
Susan M. Gallagher, RN, MSN, CNS; Blanca Crandall; Patricia S. Choban, MD; Rosaline Parson, RN, BSN, CEN, CCRN
Discuss ways to improve in physical, emotional, and social needs of obese patients; Why patients are reluctant to accept care and how that impacts skin and wound care in the hospital setting; Describe four common, predictable and preventable skin and wound complications, care suggestions; Understand the value of using appropriate equipment; Recognize the safety risks standard hospital equipment may pose for the obese patient.
James H. Kocsis, MD; Sanford Finkel, MD; Paul J. Goodnick, MD; Andrew Winokur, MD, PhD; Susan G. Kornstein, MD
Review developments in the diagnosis of patients with depressive disorders; Review approaches to treatment; Review current status of preventing relapse; Review and focus on the needs of special populations with depression.
Anthony Fauci, MD; John G. Bartlett, MD; Jose M. Gatell, MD; Roy Gulick, MD; Margaret Fischl, MD
Related implications for enhancing quality of life during combination therapy; approved drugs in the next six months by the FDA; be able to discuss major issues in antiretroviral therapy; define expectations for managing & treating HIV/AIDS; Describe differences in virologic responses using strategies of simultaneous/sequential initiation of three drug antiretrovial therapy; demonstrate reasons for differences in virologic responses using those therapies.
Mark D. Watanabe, PharmD, PhD; S. Charles Schulz, MD; Peter F. Buckley, MD
Define the demographic characteristics of schizophrenia; Appreciate the core diagnostic features of schizophrenia; Discuss which conditions mimic the presentation of schizophrenia; Understand the role of ancillary tests and other information in differentiating schizophrenia from neurological conditions; Identify new drugs available for full syndrome of schizophrenia; Distinguish the difference between the effects of traditional drugs and new drugs; Describe the current theories proposed for the pathogenesis of schizophrenia and their implications for rational drug therapy.
Jospeh J. Cahill, EMT-P; David S. Kimmel, EMT-P; Donna M. Cahill, RN
Recognize the signs and symptoms of tuberculosis; Identify the medications used for the treatment of tuberculosis; Identify the appropriate treatments for a patient suspected of having tuberculosis; Describe the appropriate personal protective equipment to be worn when treating patients with tuberculosis.
Discussion on the status of recent initiatives to create a national standard for the routine documentation and transmission of clinical and billing information related to the delivery of pharmaceutical care between pharmacy providers and third-parties.
David J. Baylink, MD; Robert Lindsay, MD; Michael J. Maricic, MD; Charles H. Chestnut, III, MD
Focuses on this prevalent disease, which is gaining increased attention as an important issue in woman's health and geriatric medicine. Program also focuses on the fundamentals of agents used for the treatment of osteoporosis, including side effects, efficacy, compliance, dosage regimen, and the need for additional drugs.
James M. Badger, RN, MS, CS; Hayden A. Duggan, EdD; Patricia A. Colonies, Med, RNC, CCRN; Anne Balboni, Med, MA, EMT-D I/C
Identifying contributing factors; Cite three common physiological stress symptoms; Three methods for maintaining clinical skills; Strategies for processing post-code reactions.
Harold Harvey, MD; Richard Santen, MD; Paul Goss, MD; Andrea Manni, MD
Topics covered in this program include: new aromatase inhibitors; risks and benefits of adjuvant tamoxifen; potential prevention of breast cancer by hormonal therapies; optimal duration therapy with tamoxifen; post-menopausal estrogen replacement therapy.
Martin Weisberg, MD; Vanessa E. Cullins, MD, MPH; James A. McGregor, MD, CM; Ron Burkman, MD; J. Kell Williams, MD; Geoffrey Redmond, MD
Diagnosing vulvovaginal candidiasis; shift of pathogens responsible; oral therapy; oral contraceptives; clinical features suggestive of androgen-related disorders; identify subgroups of women at risk; recognize modes of therapy.
Differentiate between heart failure secondary to left-ventricular systolic dysfunction and heart failure secondary to left-ventricular diastolic dysfunction; Describe the initial pharmacologic management for patients with heart failure in the setting of reduced left-ventricular systolic function; Discuss current AHCPR recommendations for patient and family education and counseling in reference to left - ventricular systolic dysfunction.
Topics covered in this program include: an overview of cystic fibrosis and discussion of new directions in therapy; respiratory viral infections; gene therapy; and the use of pulmonzyme in treatment of cystic fibrosis.
Gail Stuart, PhD, RN, CS, FAAN; Michele Laria, MSN, RN; Linda Beeber, PhD, RN; Carol Glod, MS, RN
Prominent physicians and nurses discuss the fundamentals of depression and its detection as well as treatment options for the disease. Specific topics include: definition, epidemiology, consequences and diagnosis of depression/patient education and compliance counseling; etiology of depression; treatment options - psychotherapy; treatment options - medications.
E. Clarke Ross; Bruce Davidson, MSW, CEAP; Rhonda Robinson-Beale, MD; Margo Edmunds, PhD; Ron Manderscheid, PhD
This roundtable discussion features leading managed healthcare experts discussing the new set of quality guidelines and measures for behavioral healthcare.
Brian R. Tulloch, MD; Craig Hanis, PhD; Sherwyn L. Schwartz, MD; Stanley Feld, MD
Diabetes and kidney disease current and future therapy; diabetes control and complications trials; complications and mortality rate among Mexican Americans with Type 2; introduce a system for intensive self management of Diabetes Mellitus.
Disease management of diabetes, w/ special emphasis given to the results of the DCCT trial and tight glucose control. Intensive insulin management and insulin pump therapy will also be discussed.
Roscoe O. Brady, MD; Norman W. Barton, MD, PhD; Gregory Grabowski, MD; Gregory Pastores, MD; Henry Mankin, MD
Program covers the natural history of Gaucher disease and the appropriate technology to assess the severity and predict progression. Also current molecular and enzymatic assays for ascertaining affected individuals and carriers, indications for treatment and appropriate modes of therapy, and the goals and consequences of therapeutic interventions will be discussed.
Sy Atezaz Saeed, MD; Donald W. Black, MD; Sandra Hable, RN, EdM; Timothy Bruce, PhD
Recognize and formally diagnose social phobia using DSM-IV; Differentiate social phobia from other primary and secondary anxiety disorders; Identify the behavior therapy and combined treatment for obsessive-compulsive disorder; Describe the classes of drugs most appropriate in the treatment of this disorder and factors in determining the appropriate first line treatment and followup in case of non-response.
Timothy Seay, MD; Andy Faletto-Helicopter Pilot; Thomas Flanagan, RN, BSN; Richard Cole; Paul D. Pepe, MD, MPH
Includes information about the role of first responder at a disaster scene, incident command systems, rescue efforts for critically ill patients, mass casualty incedents, how to handle the media and volunteers, and the START triage system.
Paul Shelhamer, MD; Charles Metzger, MD; Anthony Zeitman, MD; Mark Solloway, MD
A prestigious panel of physicians discussing the management of prostate cancer with specific topics including: anti-androgens and the treatment of metastatic prostate cancer; management of prostate disease in a single specialty managed care environment; neoadjuvant therapy and radiotherapy.
Celeste Lindley, PharmD; Steven M. Grundberg, MD; John D. Hainsworth, MD; Stephen L. Huber, MS, RPh
Learn about determining the emetogenic potential for chemotherapy agents; review new class system and algorithm for determining emetogenic potential of combo chemotherapy regimens. Discussions include the rationale for stratification of antiemetic dosage based on the emetogenicicity of the chemotherapy regimen; appreciating the cost and revenue comparisons for the 5HT3 antiemetics based on dosing considerations and identifing strategies for enhancing the antiemetics in a variety of practice settings.
Donna R. Smith, PhD; Alan B. Jones, PhD; Kent W. Peterson, MD
Learn five basic components of a drug-free workplace program, five types of employee drug tests and explain the difference between a regulated and unregulated drug screening; describe the purpose of drug testing and the difference between monitored and witnessed urine specimen collection; Describe the importance of the Custody and Control Form and the difference between screening and confirmation laboratory cutoff levels for illicit drugs; Recall five duties of Medical Review Officers and describe the requirements for MRO's to become certified; Explain how laboratories test for adulterants in urine.
David Metz, MD; Charles Sninsky, MD; Peter F. Malet, MD; Donald O. Castell, MD; Henry P. Parkman, MD
A group of leading physicians discuss pathophysiology and treatment of dyspepsia caused by H. pylori infection and gallbladder dysfunction, motility abnormality of the small bowel and gastroduodenal motility dysfunction, and endoscopy negative GERD as a cause of dyspepsia
Terry Lea, RN, BSN; Sabrina Bodin, RN, BSN; Anna Banford, RN
Identify the location and placement of the12 EKG leads. Explain the difference in the 12 leads and understand the advantage of using a 12 lead EKG vs. the difference between facing and opposite leads. Relate EKG changes to Patient Care. Describe the basic to advanced EKG interpretation.
This program, featuring experts in electronic fetal monitoring, will feature presentations focusing on etiology, physiology, and interventions. Specific discussions will cover periodic and early accelerations as well as variable and late decelerations.
Janice L. Zimmerman, MD; Marcus Jay Hanfling, MD; Kathleen R. Liscum, MD; Jackie Bickham, MD
Medical Complications of Drug Abuse, Pediatric Aspects of Drug Abuse, Surgical Complications of Drug Abuse (including alcohol), Psychiatric Aspects of Drug Abuse
Identify 3 chronic conditions that lead increased risk for medical emergencies, find areas where prehospital or acute care providers can assist children with special health needs, benefits of early referral to physical medical and rehab programs.
Martin G. Hellman, MD, FAAP, FACEP; Lisa Deranek, MD; Jeffrey Ekstein, MD; David Uchlcin, RN
Most common poisons encountered in the pediatric population; Assess the pertinent information in the pre-hospital setting; Discuss the pertinent pre-hospital treatment modalities; Understand common signs and symptoms of lead poisoning; Recognize the pre-hospital provider's role in averting pediatric poisoning.
Merle L. Diamond, MD, FACP; Leonard Cerullo, MD; Glen D. Soloman, MD
This program addresses issues in chronic pain management in the emergency medical setting including: the differential diagnosis of headaches, management of lower back pain and management of patients with chronic pain in the acute setting.
Thomas O'Conner, PharmD, MBA; Michael A. Mancano, PharmD; Barbara Goppold, RPh
Identify the four basic types of pharmacoeconomic analyses; Discuss and categorize the types of relevant costs; Evaluate the criteria for a well designed pharmacoeconomic study; Interpret study results; Suggest the most appropriate treatment modality based upon study results; Identify the potential value and uses of pharmacoeconomic research in the managed care environment.
Anthony Fauci, MD; John G. Bartlett, MD; Julio S. G. Montaner, MD, FRCPC, FCCP; Roy Gulick, MD; Margaret Fischl, MD
Related implications for enhancing quality of life during combination therapy; approved drugs in the next six months by the FDA; be able to discuss major issues in antiretroviral therapy; define expectations for managing & treating HIV/AIDS; Describe differences in virologic responses using strategies of imultaneous/sequential initiation of three drug antiretrovial therapy; demonstrate reasons for differences in virologic responses using those therapies.
Include:
A Strategy for International Cooperation 90 minutes
Mayo Clinic: Technology and Successful Programs in the Middle East 80 minutes
Asian Case Study 80 minutes
European Case Studies: International Experiences: Lessons Learned 60 minutes
Perry Cohen; Joseph Ober, Pharm.D; Sharon Montgomery, MA, RPh; J. Russell May, PharmD
Explains the evolution of managed care, discusses the important issues facing managed care including outcomes, disease management, and pharmacoeconomics; formulary development; explains the impact of the formulary on the pharmacist, hospital and community.
Lisa P. Gwyther, MSW; Pierre N. Tariot, MD; Cornelia Beck, PhD; Peter J. Whitehouse, MD, PhD
Awareness of what patients & families want from health professionals; behavioral intervention which can be used to decrease disruptive behaviors and functional performance; Learn the cardinal features of dementia which will permit early diagnosis.
Stanley J. Szefler, MD; Timothy Craig, DO; Sally Wenzel, MD-G; Dennis Clifton, PharmD; Robert J. Kuhn, PharmD
Major aspects of care; importance of allergy in asthma pathophysiology; practical aspects measuring the response to asthma management procedures and how they can be easily applied; opportunities for improving the cost-effectiveness of asthma treatment; define the pharmacist's role in patient compliance and managed care.
Larry Walker (program director); Michael K. Jhin; Martin S. Rash
Understand the factors most critical to consider when weighing a possible conversion; apply the basic elements of their community health leadership role when considering a potential conversion; Better understand the leadership requirements of both operating types in meeting community health needs; Develop a clear focused process for evaluating potential strategic partners in a potential conversion; Recognize various methods for building broad-based community input into the decision-making process.
Barry Kass, RPh, MBA; Judith Barr, ScD; Gerald E. Schumacher, PharmD, PhD
This program provides an introduction to health outcomes research with an examination of the links among structure, process, and outcomes in clinical interventions and health delivery systems. System-based and patient-centered outcomes will be discussed with administrative, clinical and economic examples drawn from therapeutic drug monitoring, DUR/DUE, and other pharmacy-related topics.
Hillary Rodham Clinton; panel: Michael Evans, PhD, RN, FACHE; Kathleen Smith, BS, RN, CNN; Virginia Trotter Betts, JD, MSN, RN; Carol Alexander, RN, MS; Patricia L. Starck, DSN, RN, FAAN; Diana Mason; Judith Kline Leavitt
This program addresses the effects of healthcare reform on nursing. Speakers will present an overview of the reform issues and ways in which individuals can become involved in the process. Featured are exerpts from "New Directions in Healthcare" presented by First Lady Hillary Rodham Clinton, Chairperson, President's National Health Reform Task Force, prerecorded at the American Nurses Assoc, Convention in San Antonio, TX, June 11, 1994.
Margaret Mulligan; Margaret E. O'Kane; Alfredo Czerwinski, MD
Healthplan Employer Data & Information Sets(HEDIS), comparison shopping, benchmarking for outcomes, how to best utilize existing data, the limitations of existing data, and the National Committee for Quality Assurance (NCQA0 near-term and future initiative).
Scope of nosocomial infections, cost of nosocomial infections, mortality associated with these infections, major sites for infection to occur and intervention and treatment.
Martin A. Hadelman; Joel L. Michaels; Mark A. Rucci, CEBS
Understand the impact managed care has on specific administrative and financial functions along with personnel; how compensation will change for the providers; describe disclosure obligations of the parties to a managed care provider contract as to existence of provider risk sharing and incentive arrangments; understand the rights a physician has to challenge a participation agreement with a managed care plan that has been terminated without cause; Define a "gag" clause in a provider contract.
Chris Hatcher, PhD; Scott McDonald, Atty, Littler, Mendelson Law Firm; Kris Mohandie, PhD
Recognize the legal pitfalls involved in the handling of employees when workplace violence and threats of violence arise; Learn how to avoid some of the most common problem areas; Understand the extent and past history of workplace violence in America; Indentify the five categories of Workplace Violence Risk Assessment; Discover principles of management of potentially violent workplace stations; Become informed about the myths and realities of the workplace violence problems.
Identify postpartum patients; List common early healthcare needs of the patient; Nursing interventions for identifying patients; How skilled nurses can effect change through education.
Robert B. Supernaw, PharmD; Mary J. Ferrill, PharmD; Sian Carr-Lopez, PharmD
Hyperlipidemia: Reducing Risk by Reducing Cholesterol; Should We Be Treating Patients With Medication?; Hypertension and Cardiovascular Risk: Will Controlling Blood Pressure Reduce the Risk?
Information on STD's including syphillis, gonorrhea, chlamydia, genital herpes, genital warts, trichomonasis and AIDS. Discuss treatment individuals with STD's.
Susan Simmons Holcomb, RN, MN, CCRN; Jan George, RN, BSN, CCRN; Mary Dugan Saxon, RN, MSN, CCRN
Identify typical and atypical patterns of chest pain in the acute myocardial infarction patient; Identify atpical heart rate and blood pressure presentations presenting with anterior wall vs. inferior wall myocardial infarction; Compare differences in presentation in patients with myocardial infarction who are male, young, female, elderly, and/or diabetic; State criteria for the diagnosis of myocardial infarction vs. 12-lead EKG; Identify the locations of common myocardial infarctions on the 12-lead EKG. Identify lab data currently being used to diagnose acute myocardial infarction and list immediate interventions for the patient. Identify situations in which interventional therapy may be the treatment of choice.
Randas Batista, MD; O.H. Frazier, MD; Tomas A. Salerno, MD
This program is designed for cardiologists and cardiovascular surgeons involved in the care of patients with end-stage heart disease. This program features leading cardiologists and surgeons who will explore innovative approaches for dealing with patients with severe heart disease. The tape also includes footage from actual surgical procedures with step by step narration.
Vanessa L. Kluth, PharmD; Melissa Cordell, RN; Ed Septimus, MD
Identify important factors when choosing the appropriate antimicrobial agent for a given infection; Describe the mechanism of action and spectrum of active aminoglycosides; Discuss rationale for once-daily dosing; State appropriate timing of drug sampling as it relates to aminoglycoside dosing; Understand the importance of the interpretation of results.
Virginia Strootman, RN - Marijane Barbone, RN - Sue Masoorli, RN
The objectives of this program are to distinguish the three types of central vascular access devices, explain implementation of the appropriate nursing management of central vascular access devices, and articulate the rationale for central vascular access device nursing procedures. Specific topics include: Non-Tunneled Catheters; Tunneled Catheters; Implanted Ports .
Marijane Barbone, RN; Virginia Strootman, BSN, RN, CAN; Sue Masoorli, RN
Program identifies the two most common IV related complications; lists the appropriate nursing intervention for IV complications; Verifies the importance of malpractice insurance. Specific topics addressed include: infiltration; extravasation; and legal issues.
Gary Trey, MD; Robert Carithers, MD; Eugene Schiff, MD; Howard Rosenblate, MD; Luis Balart, MD; Raymond Koff, MD; Terressa Wright, MD
Clinical overview of B&C, extra hepatic manifestations, vaccines for B, standard treatment and early treatment in asymptomatic patient Antibodies and use of PCR diagnostically, liver biopsy and prognastic indicators, hepatitis in Immunosuppressed patients: transplant recipients and HIV patients
Susan Rudd Wynn, MD; Timothy Craig, DO; Michael A. Kalimer, MD
A panel of experts comprised of allergists and physicians that have special knowledge and experience practicing in a managed care environment will address the diagnosis and treatment of common allergies from a managed healthcare perspective. The protocols discussed should be of particular interest to primary care physicians as well as allergists.
Hiroshi Mitsumoto, MD; Deborah F. Gelinas, MD; Robert G. Miller, MD; Robert C. Griggs, MD; Daniel S. Newman, MD; Gabriel T. Tatarian, DO; Sharon Hulihan, ACSW
This program will cover topics including: overview of ALS care; clinical trials of potential treatments and experimental results-IGFI and Riluzole; identifying goals of therapy and future directions for drug trials - BDNF; respiratory function; financial impact of ALS; symptomatic management and signs and symptoms of ALS .
Mary E. Muscari, PhD, CRNP, CS; Marrian Farrell, PhD, RNC, CS
Be able to describe clinical manifestations and potential complications associated with anorexia and bulimia nervosa; discuss nursing techniques used to prevent and manage the physiologic consequences; develop an understanding of the psychosocial needs of clients with eating disorders; and select psychosocial interventions based on appropriate theoretical perspectives for clients with eating disorders.
Richard M. Pope, MD; Tom D. Geppert, MD; David E. Trentham, MD; Richard P. Pollison, MD; Lee S. Simon, MD
Principles for the diagnosis of osteoarthritis and rheumatoid arthritis, importance of early recognition, conservative management of patients - both medical and physical therapy based on pathophysiologic mechanisms, expected clinical management.
David Katerndahl, MD; Laszlo Papp, MD; Eric Hollander, MD; Dennis Charney, MD and Panelist, Martha J. Haun, MD
Care-Seeking Behavior in Panic Disorder & Physician Recognition, Panic Disorders, Obsessive-Compulsive and Related Disorders, Post-Traumatic Stress Disorder and Generalized Disorders.
Leigh B. Bak, RN, MS, CDE; Kathy Heard, RN, MSN; Genevieve P. Kearney, MS, RD, CD-N
This program identifies situations when enteral nutrition via tube feeding would be indicated; identifies appropriate enteral formulas for diabetic patients receiving tube feedings; discusses complications of tube feedings and strategies to avoid and or minimize risks; states and issues unique to managing the diabetic patient who is being tube fed; identifies strategies to maintain acceptable blood sugars in patients with diabetes on enteral feedings.
Steven M. Grunberg, MD; John D. Hainsworth, MD; Paul J. Hesketh, MD; Jane Nolte, PharmD
Pharmacoeconomics of antiemetic therapy, oral antiemetics replacing IV antiemetics, appropriate use of antiemetic therapy, and the management of cisplatin-induced delayed emesis
Robert L. Spitzer, MD; K. Ranga Krishnan, MD; Sheldon H. Preskorn, MD
This program features leading medical experts presenting information on short and long term treatment of mood disorders. The faculty will address diagnosis, treatment options, clinical drug therapy, and management of mood disorders in the older patient. Additional topics wil be: polypharmacy, comorbid medical conditions, drug interactions, and the impact of depression on cognition, functions, and motor skills.
Steven F. Pariser, MD; Kimberly A. Yonkers, MD; Susan Kornstein, MD; Anthony Rothschild, MD; Lee Cohen, MD; Zachary N. Stowe, MD
Premenstrual Dysphoric Disorder; Treatment Options for the Female Patient; Menopause, Peri-Menopause, and Depression; Depression in Pregnancy and the Postpartum State.
Bogomir M. Kuhar, PharmD; Jean-Venable 'Kelly' R. Goode, PharmD, BCPS; Kim Malone, BS
Describe current rationale and epidemiology of cholesterol management. Review cardiovascular risk factors and current NCEP guidelines for treatment. List treatment approaches to achieving NCEP goals. List drug strategies and the major adverse reactions in treating hyperlipidemia. List the benefits of a pharmacy-based lipid screening and monitoring program. Explain procedures necessary for making a hyperlipidemia clinic. Identify the strategies needed to implement & keep a pharmacy-based clinic. Develop a marketing plan for a pharmacy-based clinic.
Fred Hunt, Miek McAllister, Glenn, Shively, L. Jerome Ashford
Hints for marketing managed care, effects of changes on individuals and employers, suggestions on better understanding the new environment and how to ease transitions.
Philip Pirtle, MD; Fenwick How ; Steve Coker; Ken Wheeler; Robert Doan, RN
This program will review the priorities for assessment and response in a mass casualty setting. A series of 20 victims will be presented along with a brief description of the nature of the injury and a statement of pertinent clinical status. The viewer will be asked to triage the victims into one of three categories; immediate, delayed or nonsalvageable, and list the reason for that triage decision. The panelists will then discuss the appropriate responses.
M. Jan Keffer, PhD; Loretta Kopelman, PhD; Amir Halevy, MD; Alan Meisel, JD
Identify the various conceptions of futility; what circumstances futility is consider in the clinical setting; how to determination of futility can be intergrated into clinical practice; how to make a determination of futility; various instruments used to measure futility; research being conducted; problems for society and healthcare delivery if a taxonomy of procedures might be labeled as futile.
Richard E. Thompson, MD; Maria B. Abrahamsen, Member, Dykema Gossett PLLC; William R. Fifer, MD, FACP
Develop an effective program for selecting and preparing physician leaders for their responsibilities; Understand what physician leaders must to to ensure compliance with standards within their institution; Recognize which CQI principles are applicable to credentialing; Discuss the role of attorneys in credentialing; Describe the best way to accomplish credentialing in an integrated delivery system/managed care organization.
Everett E. Vokes, MD; Philip C. Hoffman, MD; Vincent A. Miller, MD; Gregory Masters, MD; Roman Perez-Soler, MD
Familiarization with the most recent data in standard therapy for Stage IV; Discuss neoadjuvant treatment of NSCLC; Describe the role of concurrent and chemoradiation in Stage III; Identification of early clinical results of current investigation on drugs.
Barry Coleman, RPh (Moderator); T. L. Vordenbaumen, Sr., RPh; Orville A. Wagner; Dr. Jaime Kravzov
A prominent international faculty that will "explore the pharmacy implications of NAFTA with an emphasis on education and practice needs, as well as quality and pricing in drug manufacturing".
Seymour Diamond, MD; Richard B. Lipton, MD; Robert S. Kunkel, MD, FACP; R. Michael Gallagher, DO, FACOFP
Familiarizes viewers with the diagnosis and treatment of migraine headaches. A thorough discussion of the newest advances in the treatment of migraine, as well as standard forms of therapy, are presented.
Seymour Diamond, MD; Merle L. Diamond, MD,FACP; Jack A. Klapper, MD; Brian Mondell, MD
Indications and agents used in the abortive and prophylactic treatment of migraine, non-pharmacologic intervention; aspects of diagnosis and current options of episodic and chronic cluster headache, therapeutic complexities of cranial neuralgias; distinction between episodic and chronic tension-type headaches, selection of agents used in chronic tension-type headaches due to anxiety and depression; factors impacting on the differential diagnosis of headache presented in the emergency dept., and the indications for neuroradiologic testing .
Richard G. Fiscella, RPh, MPH; Richard A. Quinones, MD; Bruce I. Gaynes, OD, MS, PharmD
Define glaucoma and explain disease manifestation; List different treatment options available; Describe the traditional medical treatments available; Understand the new medical agents available and how they may change therapeutic options for the treatment of glaucoma.
Richard Payne, MD; Lillian M. Nail, PhD, RN, FAAN; Carol P. Curtis, RN, MSN, OCN; Faith Ottery, MD, PhD, FACN; Deborah M. Thorpe, PhD, RN, CS
Discuss pain initiative and its impact on our country; understand the challenges in managing cancer pain; describe principles of pain management; recognize fatigue as a side-effect of cancer treatment and understand nutritional oncology as an approach to cost/complication prevention.
Melissa Cordell, RN, BSN; Caroline Ghanbari, RD, LD, CNSD; Terry M. Lea, RN, BSN
Identify essential data utilized in determining a patient's nutritional status; discuss the appropriateness of oral, tube, or IV feedings for the critically ill patient; State 4 common parental nutrition additives; Identify the benefits of enteral nutrition vs. parental nutrition; Recognize the potential complication in tube-fed patients; Describe the 4 methods of formula administration.
John A. Rock, MD; William D. Schlaff, MD; Deborah A. Metzger, PhD, MD
Implications of add-back therapy to the length of treatment with the GnRH agonists; The appropiate time to initiate add-back therapy on a patient being treated with GnRH agonists; Diseases which can be treated with add-back therapy; Candidate profile for add-back therapy.
Anthony Lucci, MD; Russel L. Malinak, MD; Joseph R. Feste, MD; Geof Tidey, MD
These doctors address the following endometriosis issues: diagnosis and early management; classifications of treatment; operative treatment; and medical treatment and management.
Wulf H. Utian, MD, PhD; Frank Bellino, PhD; Arie Birkenfeld, MD; Matan Yemini, MD; Mary Ellen Kennedy, RN
Comprehensive Health Care to the Peri-Menopause; Current Research Trends; Hormone Replacement Therapy; What is Menopause?; Nursing Perspectives in Menopause Management.
Linda Rosenstock, MD, MPH; Scott Barnhart, MD; Linda Hawes Clever, MD, MACP
Provide clinicians and others w/ an understanding and appreciation of work-related illnesses and injuries; Recognize the role of clinical practice in preventing job-related illnesses and injuries; Describe issues involved in setting up and maintaining a clinical practice in occupational health; Develop basic questions to be asked in taking an occupational history in diagnosing and treating a work-related disorder; Understand what symptoms to look for in identifying a workplace etiology and recognize types of diagnostic tests or interventions that are indicated.
Suzanne Oppermann, RN, BSN, CPTC; Hermione Sullivan, RN, MS, CNS; Michael N. Diringer, MD; Valerie Russas
This program is designed to educate nurses and medical professionals on how donor potential is measured, how to identify and refer potential organ donors, and the many factors which should be considered in the consent process. Nurses and medical professionals will have a better understanding of their role in the organ donation process, as well as the role of the organ procurement organization.
Judd W. Moul, MD; Myra Glajchen, DSW; David G. McLeod, MD, JD; Nancy A. Dawson, MD
New paradigm of metastatic prostate cancer in the '90's; psychosocial aspects of metastatic prostate cancer and pain management; comparisons and contrasts of prostate cancer: patients vs. physicians; medicolegal aspects; medical oncology perspective of metastatic prostate cancer/pain control.
Robert N. Butler, MD; Sean Morrison, MD; Jane Morris, RN, MS; Kathleen M. Foley, MD, Robert Burt, JD
How people die in the US; Differences, if any, in the ways men and women die; The common wish of patients to die at home; Financial costs associated with medical care of the dying; Myths and truths about physician's legal responsibilities to dying patients. How to assure a peaceful death.
Walter J. Curran, Jr., MD; David S. Ettinger, MD; Chandra P. Belani, MD; Dawn Moose, MD
Integration of Chemotherapy and Radiation for Non-Small Cell Lung Cancer; New Drugs in Treatment of NSCLC; Recent Improvements in the Management of NSCLC; Management of Anorexia and Cachexia for Patients w/ NSCLC
Art Matthys, RPh; William Letender, MS, RPh; Dave Mason, RPh; Loyd Allen, PhD
Define the terms pharmacy, manufacturing, compounding, and triad; Identify areas where pharmacists can solve non-compliance problems using compounding services; List the unique dosage forms that are available to healthcare professionals. Understand how pharmacists meet the unique needs of patients at their practice sites; List the factors that exempt pharmacists from the Federal Food and Drug and Cosmetic Act; Realize the value of compounding services in terms of patient compliance and patient needs. Identify areas of practice could potentially benefit compounding; Select a course of action to take when filling a compounded prescription .
Mark Watanabe, PharmD; Barbara Poddig, PharmD, BCPP; LaGenia Bailey, PharmD; Mark E. Schneiderhan, PharmD, BCPP
Describe the therapeutic goals of using typical antipsychotic agents; Understand the common side effects of typical antipsychotic agents; Identify characteristics of "High potency" vs "Low potency" antipsychotic agents.
Robert Bohlmann; Hobart Collins; Bruce A. Johnson, JD, MPA
Discuss implementing new legal structures; Changing healthcare delivery system and economics is causing new cooperative strategies; Ways to create new organizational forms; How physicians can contract with one another; Economic independence.
Developing and governing organizations; addressing issues on structuring insurance plans and marketing plans to promote to the public; staffing and administrative issues.
Richard E. Thompson, MD; Martin D. Merry, MD; S. Harvey Price, Healthcare Industry Strategist
Understand the common mistakes made by physician board members and other board members when working with physicians; Become informed as to whether or not the policy of sustainability can be achieved in an investor-profit-taking model for delivering healthcare services; Learn how physicians can help other board members plan for what's next in our changing environment; Recognize that a physician can offer an important contribution as a trustee; Become aware of any conflicts between board membership and practicing medicine.
Anne Gawne, MD; Lauro S. Halstead, MD; Carlos, Vallbona, MD; Laura Smith, PhD, PT; Richard L. Bruno, PhD; Grace Young, OT
This program is geared towards physicians and nurses and covers topics including the impact of prescribing physical activity, selection of the appropriate techniques for management of pain, weakness and fatigue, the most effective combination of therapeutic options to arrest and/or eliminate the deterioration process, and the psychological effects of post-polio.
Laura Miller, MD; Katherine L. Wisner, MD; Susan Baab, RN, MSN, CS
Understand the clinical features of ostpartum 'blues', depression and psychoses. Understand the differences in clinical presentation and correlates, etiology and course of illness for the three categories of postpartum disorders; Identify medications which are reasonable choices for women with postpartum depression; Develop a monitoring plan for babies whose mothers take antidepressants and breastfeed; Learn the precautions of treating them under those circumstances; Gain an understanding of the best treatment options for postpartum bipolar women, including breastfeeding mothers, after a careful cost-risk analysis.
Errol L. Biggs, PhD; S. Spence Meigham, MD; John Lee, Vice President, Providence Health System
Understand responsibilities of hospital board; Describe how to complete a board self assessment program; Describe the therapy used for dealing with disruptive physicians; Learn how a disruptive physician returns to a normal colloquial relationship; Describe how the board should evaluate the CEO; Understand the chairpersons responsibilities; recognize when a disruptive physician is impared with drugs and alcohol.
Robert N. Butler, MD; Gene Cohen, MD, PhD; Myrna Lewis, MSW; Wanda Simmons-Clemmons, MD; Trey Sunderland, MD
A roundtable of world renowned geriatric specialists will address issues surrounding late life depression including warning signs, symptoms, and methods used to aid geriatric depression sufferers.
Nicholas J. Vogelzang, MD; Robert Kilbourn, MD, PhD; Robert C. Flanigan, MD; Gerald W. Chodak, MD, FACS; Howard A. Burris, III, MD
Discuss the role of single agent chemotherapy or second line hormonal therapy for managing hormone refractory prostate cancer; describe results of clinical trials using combinations chemotherapy for metastatic, hormone-refractory prostate cancer; review the role of taxanes in treating metastatic disease. Be familiar with the most recent data for treating prostate cancer.
R. Keith Campbell, RPh, FASHP, CDE; Julie C. Oki, PharmD, BCPS
Provide an update on the treatment of diabetes, including a review of the rationale for and means of achieving optimal glycemic control. Specific topics covered include: Discussion of the rationale for achieving optimal glycemic control in both type I and type II diabetic patients; Recent advances which may aid in achieving optimal glycemic control in type II diabetic patients; Methods to improve glycemic control in patients with type I diabetes.
Douglas Drossman, MD; Howard Mertz, MD; William Whitehead, PhD; W. Grant Thompson, MD; Brenda Toner, PhD
Describe the application of symptom-based criteria for diagnosis of IBS; Characterize the role of dysmotility and visceral hypersensitivity in IBS; Care of patients with IBS; Role of pharamacotherapeutic agents.
Norman Guzick, MD; Phoebe Rich, MD - John Wolf, MD; H. Irving Katz, MD
Psychosocial Ramifications and Epidemiology; Diagnosis and Differential; Current Treatment Strategies for Onychomycosis; Safety Concerns Regarding Drug Interaction Potential and Liver Metabolism
Antonio M. Calafiore, MD; Randas Batista, MD; Tomas A. Salerno, MD
This program is designed for cardiologists and cardiovascular surgeons . A live surgical procedure is shown and leading cardiologists and surgeons discuss recent progress in the battle against heart disease.
Caral Edelberg, CPC; Jack Wheeler, Professor, Univ. of Michigan
Establishment of coding and billing standards; the importance of physician chart coding; develop an understanding of efficiency counseling and problem solving; learn how to work with physicals that record documentation and billing statements accurately.
Mickey Smith, RPh, PhD; Jack Fincham, RPh, PhD; J. Lyle Bootman, RPh, PhD; Kent Summers, RPh, PhD; Albert I. Wertheimer, RPh, PhD
Describes the methods of detecting and predicting non-compliance, identifies the economic consequences of non-compliance to healthcare generally and in pharmacy practice, and discusses how to choose interventions best suited to enhance compliance.
Sharon Farley, RN, PhD; Ida R. George; Sheryl L. Threadgill
This program will cover the philosophical framework for successful professional-volunteer partnership, defining volunteer roles and different types of volunteer organization.
Sharon Farley, MD; Ida Rush George; Sheryl Treadgill
Program will cover perceived need, context of coalition, geographic boundries, stakeholder/membership, agenda, vision/mission, and organization structure.
Identify various types of STDs in women by taking sexual histories; Educate adolescents on healthy behaviours; Recognize the types of STDs that require and/or treatment; Recognize that patients may have coexisting STD's; Identify resources for recommended treatments; Identify high risk behaviours through history and a physical; Counsel sexually active women in choosing contraceptives methods that will reduce their risks of STD's; Educate women on gender-related risk factors for acquiring STD's.
Roy T. McKay, PhD; Philip Harber, MD, MPH; James E. Lockey, MD, MS
Be able to describe how to apply current standards to obtain acceptable spirometry tests; identify indications for spirometry testing; learn how to categorize types and patterns of spirometry curves with respecit to normal, obstructive and restrictuve patterns; recognize how to identify and categorize the level of disability and impairment from spirometry test results.
James E. Orlikoff, President, Orlikoff & Associates; Carl W. Thieme, President, Cambridge Research Institute; Dorothy Bellhouse, VP, Corporate Strategy, Communicare Health System
Understand the strategic planning process, and it's importance to the future of your healthcare organization; Understand the role of the board in the strategic planning process; Have the tools to to establish and oversee their own strategic planning process; Understand the components of an effective strategic plan, and significant environmental issues that most strategic plans should address; Know the most common pitfalls of and barriers to strategic planning, as well as how to avoid them.
Scott Roman (Attorney at Law); David S. Wanger, CEO; Donald E. Cole, MD (VP)
Forming Integrated Delivery Systems; Garnering Support for Integrated Delivery Systems; Using Integrated Delivery Systems for Proprietary Managed Care Products
This program will train the nurse in some of the latest techniques to mitigate or alleviate stress induced by the caregiver's workplace. Several options are highlighted that can be implemented in the workplace to reduce the impact of stress causing events.
Kenneth R. Cohen; Johnathan Peck, MA; Judith K. Jones, MD, PhD; Eleanor M. Vogt, RPh, PhD
This panel of forward thinkers will examine healthcare in a whole new way - defining relationships in what seems to be a chaotic sea of independently managed treatment components. This program will provide understanding of the concepts of management, disease management, and integrated health data management systems.
J. Herbert Patterson, PharmD; Michael B. Bottorff, PharmD; Barry Bleske, PharmD
Pathophysiology of heart failure and it's role in contributing to the morbiity and mortality of heart failure; be able to identify the most appropriate therapy for a patient to optimize outcomes; when a specific therapy is contraindicated, be able to identify alternate appropriate therapies to optimize therapeutic outcomes. Be able to list potential drug therapies that may be useful for heart failure.
Frederick Pfeiffer, PharmD; Richard Herrier, PharmD, CPE
Assess the impact of medication nonadherance to the overall cost of healthcare in the US; Determine the need for patient education regarding medications for hypertension as it relates to drug defaulting; Determine the role of common annoying side effects with diuretics in the perpetuation of therapeutic nonadherance; Describe three misconceptions regarding compliance issues; List three main factors that are required for optimal patient compliance.
Richard P. Wenzel, MD, MSc; Robert C. Moellering, Jr., MD; Issam Raad, MD, FACP; W. Michael Scheld, MD; Jerome J. Schentag, PharmD
Nationally renowned faculty of medical experts giving presentations on gram positive aerobic infections and resistance to treatment. Special emphasis is given to advanced studies in treating various infections.
Discuss the importance of trauma in pregnancy and emphasize the team approach; discuss frequency & types of trauma seen during pregnancy; know of physiological changes during pregnancy that affect the management of a trauma victim; discuss abruptio placenta; uterine rupture, amniotic fluid embolism; and penetrating uterine trauma; be aware of history and physical assessments in the field; discuss pre-hospital management, stabilization, transport issues; contact with the receiving hospital and special circumstances such as burns, electrical injuries and cardiac arrest.
Aman U. Buzdar, MD; I. Craig Henderson, MD; Howard Hochster, MD
Discuss the diagnosis and treatment of breast cancer; Presentations on 1st and 2nd line treatments will cover cytotoxic chemotherapy (CMF, CAF, and new cytotoxic agents); Diverse hormonal agents, neoadjuvant treatments, and combination therapies.
This program is designed to give family care physicians, as well as other healthcare professionals, a better understanding of diabetes mellitus.The program features a leading medical expert giving a presentation on the treatment of Type 2 diabetes based upon its pathophysiology. The program also addresses goals for treatment, currently available medications and the prevention of complications
Marlene Link, RN, MN; Jan George, RN, BSN, CCRN; Susan Simmons Holcomb, RN, MN, CCRN
State the artery which when blocked can lead to "true"AVB's of first degree and second degree type I. State the artery which when blocked can lead to second degree type II and third degree heart block. Distinguish between narrow QRS tachycardias. Identify treatment modalities for narrow QRS tachycardias. State which bundle is "blocked" in aberrancy and the pattern. QRS morphology takes to indicate aberrancy. Identify QRS axis criteria to distinguish between aberrancy verses ventricular tachycardia and list the treatment for VT.
Richard E. Thompson, MD; Martin D. Merry, MD; S. Harvey Price, Healthcare Industry Strategist
Recognize common mistakes made by those responsible for proposing new candidates for membership on the board; Learn how to avoid common mistakes made by individuals accepting appointments to the board of a healthcare organization; Identify the three most important points in orienting new board members; Understand a newly appointed board members responsibilities; Describe the economic and political issues that trustees are exposed to while on the board.
Margaret W. Berrio, RN, MS; Donna DeMartino, RN; Maureen Levesque, RN; Norma Fortin; Lisa Walker
Define the patient's right to self determination; Describe the historical perspective surrounding the PDSA; Identify approaches that may be used to communicate choices for medical care at the end of life; Identify factors that influence decision-making for healthcare at the end of life; Identify approaches to resolving conflict among health care agents caring for a patient with an ADHC; Describe the role of the nurse regarding Advance Directives; Discuss strategies to facilitate the Advance Directives process; Define the implications for decision-making as a Health Care Proxy Agent; Describe a family's experience with the Advance Directive process.
Kenneth H. Mayer, MD; Anthony S. Fauci, MD; David Ho, MD, Michael S. Saag, MD; Margaret Fischl, MD, John W. Mellors, MD; John Stansell, MD, Paul A. Volberding, MD
Pathogenesis of HIV infections; Role of new technology; Choice of initial and salvage antiretroviral therapy; Economic impact; factors for the decline in AIDS related mobidity and mortality.
Joseph Oesterling, MD; Reginald Bruskewitz, MD; Michael L. Blute, MD; John H. Lynch, MD; John N. Kabalin
New invasive BPH therapies, standard therapies for BPH, transurethral microwave thermal therapy, electrovaporization laser for BPH, alpha blockers old and new.
Reginald Bruskewitz, MD; Joseph Osterling, MD; John N. Kabalin, MD, FACS; Claus G. Roehrborn, MD; John H. Lynch, MD; Kevin M. Slawin, MD; Herb Lepor, MD; Patricia Meyers, RN
This program features presentations from leading medical experts on the symptoms, management and treatment of BPH. Topics discussed will include: medical therapy, TURP & TUIP, laser prostatectomy, trans-urethral needle ablation, treatment guidelines, thermal therapy, and high intensity focused ultrasound .
Edward P. Armstrong, PharmD; Frederick Pfeiffer, RPh, MS, PharmD; Tim Sawyers, RPh, MBA, CDE
Provide information for using claims data to assess drug therapy; Analyze claims data to determine non-adherence to chronic medications; Understand how to access medical and pharmacy claims; Differentiate medical from pharmacy claims data and report generation; Identify specific depressions management problems in a managed care setting.
Explain revenue reimbursement in a managed care environment; discuss analysis of a capitation contract; Explain how capitation affects the financial structure of physician practice; Explain why capitation requires productivity measures; distinguish between objective and subjective outcome measures; explain how quality is measured in a managed care environment.
Susan Simmons Holcomb, RN, MN, CCRN; Marlene Link, RN, MN; Jan George, RN, BSN, CCRN
Identify fixed versus modifiable risk for women who develop heart disease; State the differences between men and women undergoing diagnostic procedures such as exercise stress tests; List the differences in the outcomes of women vs. men under interventional cardiology procedures. Compare the presentation of signs and symptoms between men and women presenting to the Emergency Department with Ischemic-type chest pain; Identify differences between treatment modalities for men and women presenting to the Emergency Department with Ischemic-type chest pain.